Purpose. Streptococcus pyogenes, a notorious human pathogen that is responsible for various invasive and non-invasive diseases, possesses multiple virulence armaments, including biofilm formation. The current study demonstrates the antibiofilm and anti-virulence potential of fukugiside, a biflavonoid isolated from Garciniatravancorica, against S. pyogenes.
INTRODUCTION
Streptococcus pyogenes, also known as group A Streptococcus, is a devastating bacterial pathogen that is restricted to human hosts [1] . It generally causes mild to modest infections in the respiratory tract (tonsillitis, pharyngitis) and skin (pyoderma). However, it can invade deeper tissues and cause invasive infections, such as septicaemia, streptococcal toxic shock syndrome and necrotizing fasciitis. In addition, repeated infections may trigger post-infection immune sequelae, including acute post-streptococcal glomerulonephritis, rheumatic fever and rheumatic heart disease [2] . It is placed as the ninth leading cause of human mortality, with an estimated~18 million cases and >500 000 deaths per year globally [3] .
The pathogen is armed with virulence factors of all classes that facilitate its adherence to host cells, subvert the host innate immune system and disseminate infection. Important virulence factors include antiphagocytic M protein, hyaluronic acid capsule, haemolytic exotoxins, extracellular cysteine protease, NAD glycohydrolase and DNase [4] . It is also capable of forming biofilm in vivo, which has been reported to play an important role in pathogenicity [5, 6] . Nearly 90 % of S. pyogenes strains isolated from diverse clinical sources were found to have the capacity to form biofilm [7] , indicating its role in establishing infection. The expression of virulence factors and biofilm formation are modulated by intricate regulatory mechanisms involving twocomponent systems (TCSs), stand-alone regulators and quorum sensing [8] . Well-studied regulatory mechanisms include the CovRS TCS, the LuxS quorum sensing system and stand-alone regulators such as Mga and Srv.
The cells residing in biofilm exhibit unique features, such as reduced growth rate and altered metabolism, compared to their planktonic counterparts. These features, along with the three-dimensional architecture of biofilm, protect biofilm cells from antimicrobial agents, leading to therapeutic treatment failure. Indeed, biofilm-forming S. pyogenes strains were found to have increased minimum microbial eradication concentrations for all contemporary antibiotics used for treatment [9] . Moreover, continued and inappropriate use of antibiotics has led to multidrug resistance among S. pyogenes strains, causing global concern. For instance, clinical strains isolated globally between 1990 and 2000 were found to be multidrug-resistant, with 38 % of strains being resistant to tetracycline, 25 % being resistant to erythromycin and 15 % being resistant to both [10] . Anti-biofilm agents, which inhibit biofilm formation and potentiate the action of antimicrobial agents and host immune cells, are considered to be a promising alternative. These agents act by interfering with the regulatory mechanism that governs biofilm formation without imposing selection pressure and thus lower the likelihood of the development of resistance [11] . Since the mechanisms governing biofilm formation and virulence overlap in S. pyogenes [1, 12] , anti-biofilm agents are also expected to inhibit virulence.
Several independent studies have shown the diverse bioactive potential of Garcinia spp. [13, 14] . The secondary metabolites from Garcinia spp. have been reported to have anticancer, anti-inflammatory, antibacterial, antiviral, antifungal, anti-HIV, antidepressant and antioxidant properties [15] [16] [17] . However, they have seldom been explored for their anti-biofilm property. With this background, the present study explores the anti-biofilm and anti-virulence potential of fukugiside, a biflavonoid isolated from the leaves of Garcinia travancorica (a species endemic to the Western Ghats, India) against S. pyogenes. The study also attempts to identify the plausible mechanism of action of fukugiside, its toxicity and its in vivo efficacy.
METHODS

Bacterial strains and growth conditions
The reference strain S. pyogenes SF370 (M1 serotype; ATCC 700294D-5) and five clinical isolates belonging to different M serotypes [SP5 (M56; GenBank accession number: EU636227), SP7 (st38; EU636229), SP11 (M65; EU660377), SP30 (M100; EU660379) and SP31 (M74; EU660380)] were used in this study. Tryptone agar (Hi-Media Laboratories, India) and Todd Hewitt broth (Hi-Media Laboratories, India) supplemented with 0.5 % yeast extract and 1 % glucose (THYG broth) were used to culture bacteria. Overnight cultures of S. pyogenes strains containing~2.3Â10 5 c.f.u. ml À1 were considered to be standard cell suspensions.
Fukugiside Fukugiside (Fig. 1a) was isolated from G. travancorica, a plant species endemic to the Western Ghats of South India [14] . The stock was prepared by dissolving fukugiside (20 mg ml
À1
) in dimethyl sulphoxide (DMSO) and stored at 4 C until further use.
Determination of the minimum biofilm inhibitory concentration (MBIC)
The MBIC of fukugiside against the reference strain, S. pyogenes SF370, was determined by the microdilution method in a 24-well polystyrene plate (Nest Biotech Co., Ltd, People's Republic of China). Briefly, 1, 2, 3, 4, 5 and 6 µl of fukugiside (20 mg ml À1 ) was added individually with 1 ml of assay broth (THYG) to attain final concentrations of 20, 40, 60, 80, 100 and 120 µg ml À1 , respectively. Each well was inoculated with 1 % of standard cell suspension. The final volume of DMSO in each well was made up to 1 %. Wells containing 1 % DMSO alone were considered to be a control (negative/vehicle control). The plate was incubated at 37 C under static conditions for 24 h. Subsequently, planktonic cells were removed from each well and the wells were washed with sterile distilled water to remove loosely bound cells. Bacterial cells that had adhered to the wells were stained using 0.4 % crystal violet (w/v) for 10 min, after which the wells were washed thrice with sterile distilled water to remove unbound stain and allowed to air dry. The bound stain was removed using 1 ml of 20 % glacial acetic acid (v/v) for 10 min and the absorbance was read at 570 nm. The amount of crystal violet stain extracted from the wells was proportional to the number of cells in the biofilm. Hence, a decrease in absorbance at 570 nm in the treated wells signified biofilm inhibition. The percentage of biofilm inhibition was determined using the formula: % of inhibition=[(control OD 570 nm -treated OD 570 nm)/control OD 570 nm]Â100. The minimum concentration of fukugiside that exhibited maximum biofilm inhibition was considered to be the MBIC [18] .
Confocal laser scanning microscopy (CLSM)
Microscopic analysis was performed to study the effect of fukugiside on biofilm architecture. For CLSM, 1Â1 cm glass pieces were placed in 24-well polystyrene plates containing 1 ml of THYG medium and 1 % standard cell suspension of S. pyogenes strains (SF370 and five clinical isolates) supplemented with fukugiside (80 µg ml À1 ) or not. The plate was incubated for 24 h at 37 C. Following incubation, the glass pieces were removed and washed with sterile distilled water. The cells bound to them in the form of biofilm were stained with 0.1 % acridine orange for 5 min, washed again with distilled water to remove excess stain and air-dried. Subsequently, the biofilm architecture was visualized and documented under CLSM (LSM 710, Carl Zeiss, Germany) [19] .
Scanning electron microscopy (SEM)
The biofilm of S. pyogenes SF370 was allowed to grow on glass pieces in the absence and presence (80 µg ml
À1
) of fukugiside, as described above. The biofilms were washed with sterile phosphate-buffered saline (PBS) and fixed with 2 % glutaraldehyde overnight at 4 C. Following fixation, the biofilms were washed again with sterile PBS and dehydrated gradually using increasing concentrations of ethanol (20, 40, 60 , 80 and 100 %). The slides were air-dried at room temperature, gold-coated and observed under a scanning electron microscope (Jeol-JSM 5600LV) [19] .
Extracellular polymeric substance (EPS) measurement EPS, the cementing material of biofilms, is mainly composed of polysaccharides. Hence, the effect of fukugiside on EPS was assessed by measuring the total carbohydrate using the phenol-sulphuric acid method. The S. pyogenes strains (SF370 and five clinical isolates) were grown in the absence and presence (80 µg ml
) of fukugiside for 24 h at 37 C in THYG broth. Following incubation, the cells were harvested by centrifugation (10 000 r.p.m. for 10 min) and washed thrice with sterile PBS and resuspended in 200 µl of the same. Subsequently, 200 µl of a reaction mixture containing an equal volume of 5 % phenol and five volumes of concentrated sulphuric acid containing 0.2 % hydrazine sulphate was added to the cell suspensions, mixed well and incubated in the dark at room temperature for 1 h. The samples were centrifuged at 10 000 r.p.m. for 10 min, and the absorbance of the supernatants was measured at 490 nm [18] .
Microbial adhesion to hydrocarbon (MATH) assay
A MATH assay was performed to assess the effect of the fukugiside on the cell surface hydrophobicity of S. pyogenes. The cultures (SF370 and clinical isolates) were grown in the absence and presence (80 µg ml À1 ) of fukugiside for 24 h at 37 C in THYG broth. The cultures were diluted to obtain OD 0.4 at 600 nm. One millilitre of toluene was added individually to 1 ml of the diluted cultures, vortexed thoroughly and allowed to stand at room temperature for aqueous/solvent phase separation. The cells retained in the aqueous phase were quantified by measuring absorbance at OD 600 nm. The percentage of hydrophobicity was calculated by the formula: % hydrophobicity=[1 À (OD 600 nm after vortexing/OD 600 nm before vortexing)]Â100 [20] .
Secreted protease quantification
The total secreted protease of the control and the fukugiside-treated (80 µg ml À1 ) S. pyogenes was quantified using an azocasein assay as described by Hollands et al. [21] . The cultures (SF370 and five clinical isolates) were centrifuged at 12 000 r.p.m. and the supernatants were filter-sterilized through a 0.2 micron nylon membrane filter. An equal volume of activation buffer (1 mM EDTA, 20 mM DTT in 0.1 M sodium acetate buffer, pH 5.0) was added to the cellfree culture supernatants and incubated at 40 C for 30 min. Then an equal volume of 1 % (w/v) azocasein was added to the samples and incubated for 1 h at 40 C. Subsequently, trichloroacetic acid (10 %) was added and mixed thoroughly to precipitate the protein and thereby stop the reaction. The samples were centrifuged at 12 000 r.p.m. for 5 min and the supernatants were read at 440 nm. Activity was expressed as the change in absorbance value.
Blood survival assay
The effect of fukugiside in inhibiting the ability of S. pyogenes to evade opsono-phagocytosis was evaluated using a blood survival assay. Briefly, fukugiside-treated (80 µg ml
À1
) and untreated S. pyogenes SF370 were allowed to grow overnight. Fifty microlitres of these overnight cultures was added individually to 450 µl of healthy human blood and mixed gently. The mixtures were incubated for 3 h at 37
C. The viability of the cells in the control and treated samples was quantified by the spread-plate method on tryptose agar plates. The percentage of cells that survived opsono-phagocytosis in the blood was calculated using the formula: % of survival=[colony-forming units (c.f.u.) of test/c.f.u. of control]Â100 [22] .
Real-time PCR (qPCR) analysis
Total RNA of S. pyogenes SF370 grown in the absence and presence (80 µg ml
À1
) of fukugiside for 24 h was isolated according to the method described by Oh and So [23] . Reverse transcription of the isolated RNA samples was performed using the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems) as per the manufacturer's directions. Real-time PCR was performed with gene-specific primers of mga, covR, covS, slo, col370, dltA, htsA, srv, speB, hasA, ropB, luxS and gyr genes (Table 1 ) in a 7500 Sequence Detection System (Applied Biosystems, Inc., USA) using FastStart Universal SYBR Green Master Mix (Roche, Switzerland). The housekeeping gene, gyr (gyrase) was considered to be the internal control. The real-time PCR cycle included an initial denaturation at 94 C for 5 min, followed by a 30-cycle amplification consisting of denaturation at 94 C for 45 s, annealing at 58.5 C for 45 s and an extension at 72 C for 30 s, with a final extension at 72 C for 10 min. Amplification data were collected using ABI sequence detection 1.3 software (Applied Biosystems Inc., USA). The expression pattern of genes was quantified by 2 ÀDDCt calculation.
Caenorhabditis elegans survival assay
The toxicity of fukugiside, if any, and its influence on S. pyogenes SF370 virulence was evaluated in vivo using a C. elegans survival assay. The toxicity of the compound was assessed by determining the survival percentage of countable numbers (~10) of L4 stage worms in the absence and presence (80 µg ml À1 ) of fukugiside in 1 ml of M9 medium, supplemented with~1000 c.f.u. ml À1 of Escherichia coli OP50, the laboratory food source for C. elegans. The survival rate of the worms was monitored every 4 h. The worms were considered to be dead when they did not show any response to external stimuli, such as a gentle touch or tap with a platinum loop. Similarly, the effect of fukugiside on S. pyogenes SF370 virulence was evaluated by comparing the survival percentage of S. pyogenes SF370-infected (~1000 c.f.u. ml À1 ) worms grown in the absence and presence (80 µg ml À1 ) of fukugiside. Worms grown in the presence of an equivalent amount of DMSO served as a vehicle control in both the toxicity test and the S. pyogenes virulence evaluation [22] .
Statistics
All of the experiments were carried out at least thrice independently. One-way analysis of variance (ANOVA) was performed using the SPSS software package (Chicago, IL, USA) to determine the statistical differences between the control and treated samples. P 0.005 was considered to be significant.
RESULTS
Fukugiside inhibits biofilm formation of S. pyogenes irrespective of M serotype Fukugiside was preliminarily assessed for its anti-biofilm activity using the reference strain, S. pyogenes SF370, belonging to the M1 serotype. A dose-dependent anti-biofilm was observed, with a maximum inhibition of 91 % being observed at a concentration of 80 µg ml
À1
. Concentrations above 80 µg ml À1 did not exhibit any significant increase in biofilm inhibition. Hence this was fixed as the MBIC and further experiments were performed at this concentration (Fig. 1b) . Growth analysis using spectrophotometry revealed no significant changes between the control and the fukugiside-treated samples, confirming that the observed biofilm inhibition was not due to growth inhibition. The efficacy of fukugiside's biofilm inhibition at the MBIC was also evaluated against different M serotypes of S. pyogenes. Fukugiside significantly reduced the biofilm formation of all M serotypes tested (79 to 96 %) at 80 µg ml À1 (Fig. 2) . Table 1 . List of primers used in the present study
Gene
Primer sequence (5¢À3¢)
Forward Reverse
Microscopic analysis CLSM images of 24 h-old fukugiside-treated S. pyogenes biofilms (SF370 and five clinical isolates belonging to different M serotypes) displayed distorted three-dimensional architecture and fewer micro-colonies compared to their corresponding controls (Fig. 3) . SEM images of the S. pyogenes SF370 control showed very thick biofilm formation with multiple layers (Fig. 4) . By contrast, treated sample showed decreased biofilm formation with an apparent reduction in EPS.
Fukugiside mitigates EPS and cell surface hydrophobicity In order to confirm the reduction in EPS production upon fukugiside treatment, EPS was quantified using the phenolsulphuric acid method. Fukugiside treatment (80 µg ml À1 ) significantly reduced the EPS production (38 to 90 %) of all the M serotypes tested (Fig. 5a ). Because cell surface hydrophobicity plays a key role in biofilm formation, this was also measured. Fukugiside treatment considerably reduced the cell surface hydrophobicity of all the M serotypes (Fig. 5b) .
Fukugiside enhances extracellular cysteine protease production
The effect of fukugiside (80 µg ml
À1
) on the production of the extracellular cysteine protease (major secreted protease) of S. pyogenes was evaluated qualitatively using the azocasein assay, wherein the amount of coloured azo dye released into the suspension after proteolytic cleavage of the substrate (azocasein) was measured. The amount of dye released directly reflects the amount of protease production. Fukugiside was found to significantly enhance the protease production of all the M serotypes (Fig. 6) .
Fukugiside renders S. pyogenes susceptible to opsono-phagocytosis
The effect of fukugiside in inhibiting the ability of S. pyogenes SF370 to evade opsono-phagocytosis was assessed by enumerating the number of cells that survive after exposure to healthy human blood. Fukugiside (80 µg ml À1 ) proved to be efficient in rendering S. pyogenes vulnerable to phagocytosis. The treated samples showed only a 10 % survival rate, whereas in the control a 55 % survival rate was observed (Fig. 7) .
Fukugiside affects the expression of genes involved in biofilm and virulence A profound downregulation was observed in the expression levels of the mga, htsA and hasA genes (3.6-, 3.7-and 2.9-fold, respectively). Significant downregulation was observed in the covS, slo, col370, dltA and srv genes, with a reduction in their expression levels of 2.1-, 2.1-, 2.0-, 2.4-and 2.0-fold, respectively. On the other hand, the expression levels of the speB and luxS genes were found to be significantly upregulated (1.2-and 0.6-fold, respectively). The expression levels of the covR and ropB genes were weakly upregulated (0.3-fold) (Fig. 8) .
Fukugiside inhibits biofilm and virulence in vivo
The survival rate of C. elegans grown in the presence of a vehicle control (DMSO)+ E. coli OP50 and fukugiside (80 µg ml
À1
) + E. coli OP50 was found to be similar, demonstrating the nontoxic nature of fukugiside. On the other hand, fukugiside treatment enhanced the survival rate of S. pyogenes SF370-infected C. elegans significantly. In the current experimental setup, S. pyogenes SF370 caused complete killing (100 %) of worms at 96±2 h. However, at the same time, only 67 % killing was observed in fukugidetreated worms (Fig. 9) .
DISCUSSION
The ability of S. pyogenes to form biofilm in vivo and the production of a myriad of virulence factors have enabled them to evade the host immune system and develop resistance against antibiotics [7, 9] . In this context, anti-biofilm agents, which inhibit biofilm formation and thereby expose the pathogen to host immune response and antibiotics, have gained prominence for therapeutic treatment in recent times [1, 12, 18] . The present study explores the in vitro and in vivo anti-biofilm property of fukugiside, a biflavonoid isolated from G. trvancorica, against S. pyogenes. Although the antioxidant and cytotoxic activities of fukugiside have been reported [14] , to the best of our knowledge it has seldom been explored for its anti-biofilm property.
A quantitative assay to evaluate the anti-biofilm activity of fukugiside was performed against S. pyogenes SF370 (M1 serotype), a reference strain reported to cause infections worldwide [24] . Fukugiside exhibited concentration-dependent anti-biofilm activity. Fukugiside at a concentration of 80 µg ml À1 displayed 91 % biofilm reduction, and this was considered to be the MBIC (Fig. 1) . It did not affect the growth of the pathogen, indicating that the observed biofilm inhibition is independent of bacterial viability. An epidemiological study by Esposito et al. [25] revealed an association between M serotypes that are specific to certain diseases and the differential distribution of the M serotypes across the globe. Hence, the anti-biofilm activity of fukugiside was quantified against different M serotypes of S. pyogenes. Fukugiside was able to significantly inhibit the biofilm formation of S. pyogenes, irrespective of their M serotype (Fig. 2) . In comparison, compounds such as 3-Furancarboxaldehyde [22] and morin hydrate [26] have been reported to exhibit 90 and 50 % anti-biofilm activity at concentrations of 132 µg ml À1 and 225 µM, respectively. On the other hand, limonene, a cyclic monoterpene from the rind of citrus fruit, was reported to exhibit approximately 75-95 % biofilm inhibition at a much higher concentration of 400 µg ml À1 against multiple M serotypes [27] . 2,4-Di-tertbutylphenol (DTBP), isolated from the seaweed surfaceassociated bacterium Bacillus subtilis, exhibited 79 % biofilm inhibition at 48 µg ml À1 against the M1 serotype [18] . Though DTBP exhibited biofilm inhibition at a lower concentration than fukugiside, it also exhibited mild bacteriostatic activity. However, fukugiside did not exhibit any such bacteriostatic activity, making it an ideal anti-biofilm agent. CLSM analysis also confirmed the anti-biofilm activity of fukugiside against different M serotypes, with a conspicuous decrease in micro-colony formation and biofilm thickness in treated samples compared to the control (Fig. 3) .
SEM images of 24 h-old S. pyogenes SF370 (reference strain) biofilm grown in the absence and presence of fukugiside were taken to study the effect of fukugiside on the biofilm architecture of S. pyogenes. The SEM images revealed that fukugiside inhibits biofilm biomass and extracellular polymeric substance (EPS) (Fig. 4) . To further confirm decreased EPS synthesis upon fukugiside treatment, the same was quantified using the phenol-sulphuric acid method, and a 38 to 90 % reduction in EPS synthesis was observed in all the tested M serotypes (Fig. 5a) . EPS (comprising polysaccharides, proteins and DNA) plays an important role in the formation of biofilm architecture and maintaining the mechanical stability of biofilm [28] . It also prevents the entry of host immune cells and antimicrobial agents, resulting in therapeutic treatment failure [29] . Hence, decreased EPS synthesis upon fukugiside treatment entails enhanced susceptibility of S. pyogenes to antimicrobial therapy and clearance by host immune cells.
Cell surface hydrophobicity is an important factor in biofilm development, as it assists in the adhesion of bacteria to the substratum, which is the primary and essential step in biofilm formation cascade [30] . Thus, compounds that reduce cell surface hydrophobicity are expected to deter biofilm formation [31] . The results of the MATH assay showed that fukugiside treatment significantly reduces the cell surface hydrophobicity of all the tested M serotypes of S. pyogenes (Fig. 5b) . In comparison, in studies with coralassociated actinomycetes the cell surface hydrophobicity was only affected by 30-50 % [32] , whereas in a study with plant extracts there was no reduction [20] . Lipoteichoic acid (LTA), an important cell wall component of Gram-positive bacteria, including S. pyogenes, is critically responsible for cell surface hydrophobicity [33] . An arlier study by Miorner et al. [34] reported that the dltA gene is involved in the Dalanylation of LTA. Independent studies carried out by Gross et al. [35] and Fabretti et al. [36] proved that mutations in the dltA gene of Staphylococcus aureus and Enterococcus feacalis reduce their ability to form biofilm. Hence, the expression profile of dltA was assessed upon fukugiside treatment and, as anticipated, it was found to be downregulated by 2.4-fold (Fig. 8) .
On the other hand, fukugiside treatment enhanced extracellular protease production in all the tested M serotypes (Fig. 6) . Although S. pyogenes secrete multiple proteases, streptococcal pyrogenic exotoxin B (SpeB) is the predominant extracellular protease. It plays a key role in virulence by degrading immune modulators and host matrix proteins, and facilitates host tissue damage and dissemination [4] . Interestingly, SpeB also degrades the peptides that stabilize the biofilm matrix and thus regulates biofilm formation and dispersal [37, 38] . Hence, the enhanced protease production observed upon fukugiside treatment would deter biofilm formation by proteolysis. To further assess this hypothesis, real-time PCR was performed, which showed the upregulation of speB by 1.2-fold (Fig. 8) .
The expression of speB was controlled by the stand-alone regulators RopB and Srv. While RopB positively regulates speB, Srv negatively regulates the same [39, 40] . Hence, the expression of ropB and srv was assessed and, as anticipated, the former was found to be upregulated and the latter was downregulated (Fig. 8) . Altogether, the results of the MATH assay, extracellular protease quantification and gene expression analysis suggest that the combined effects of reduced cell surface hydrophobicity (caused by dltA downregulation) and enhanced protease production (caused by speB and ropB upregulation and srv downregulation) are the primary reason for decreased biofilm formation upon fukugiside treatment.
M proteins, a key virulent factor of S. pyogenes, provide antiphagocytic functions, which are critical for the survival of S. pyogenes in human tissues and fluids. They also mediate adhesion to host epithelial cells and promote invasive infections [41] . The effect of fukugiside on M proteins was evaluated using a blood survival assay, which measures the susceptibility of S. pyogenes to phagocytosis. Similar to other reported anti-biofilm agents, such as 2,4-Di-tert-butylphenol [18] and limonene [27] , fukugiside significantly reduced the survival of S. pyogenes in healthy human blood (from 55 % to 10 %). M proteins, encoded by the emm gene, are positively regulated by mga, a stand-alone regulator [38] . Fukugiside downregulated mga by 3.6-fold, validating the blood survival assay results. The obtained results suggest that fukugiside would prevent the systemic spread of S. pyogenes by deterring its immune evasion. htsA, a component of the HtsABC transporter, also called the streptococcal iron acquisition (SiaABC) transporter, was found to be downregulated significantly (3.7-fold) in the present study. HtsA is involved in iron acquisition, which is essential for S. pyogenes survival [42] . The capacity for iron uptake has been shown to affect its virulence, which is evident from mutants that are defective in heme uptake [43] . Hence, a reduction in htsA expression might impair S. pyogenes' ability to acquire iron, and the unavailability of iron might alter the virulence of the pathogen.
Fukugiside also upregulated luxS by 0.6-fold. luxS is responsible for the synthesis of autoinducer-2, which is involved in quorum sensing. Marouni and Sela [44] have demonstrated that the inactivation of luxS causes enhanced M protein and reduced SpeB. This observation goes in parallel with the present study, in which the upregulation of luxS (Fig. 8 ) decreased M protein (Fig. 7) and enhanced SpeB (Fig. 6) . covS, which encodes the sensor kinase of the CovRS TCS (by far the best characterized TCS), was found to be downregulated significantly (2.1-fold). It directly and indirectly influences~15 % of S. pyogenes' genes, including those involved in virulence factor production (SpeB, HasA) and stand-alone regulators (Mga) [45] .
The real-time results also showed remarkable downregulation of important virulence factors, such as mga (positively influences M protein), hasA (involved in hyaluronic acid synthesis), slo (involved in streptolysin O synthesis) and col370 (a collagen-like surface protein) (3.6-, 2.9-, 2.14-and 2-fold, respectively). Each of these genes has a distinct function and they enable the pathogen to attach to host tissue, evade immune system and establish infection, thus playing a crucial role in S. pyogenes pathogenesis. For instance, the M protein and hyaluronic acid protect the pathogen from phagocytosis, streptolysin O is a host membrane-damaging protein and Col370 promotes adhesion to epithelial cells [8] . Hence, it was speculated that downregulation of these genes would impair the virulence of the pathogen. To confirm this, in vivo analysis was performed in C. elegans, a simple eukaryotic nematode model [46] . The nematode conserves many of the human genes involved in disease and cellular pathways [47] , and thus is widely used for studying bacterial pathogenesis. It is apparent from the survival assay results that fukugiside decreases the virulence of S. pyogenes (Fig. 9) . The results also proved the nontoxic nature and in vivo efficacy of fukugiside. In comparison, the compound 3-Furancarboxaldehyde was reported to increase the virulence of S. pyogenes, despite its significant anti-biofilm activity [22] . Hence, the inhibitory effect of fukugiside on both the biofilm formation and virulence of S. pyogenes that was observed in the present study augurs well for its utility in clinical applications.
To sum up, the results of the present study exhibit the in vitro and in vivo anti-biofilm activity of fukugiside against different M serotypes of S. pyogenes. They suggest that fukugiside impedes biofilm formation by decreasing cell surface hydrophobicity and enhancing extracellular protease production. On the other hand, a remarkable decrease in the expression of mga, slo, hasA and col370 was considered to be the reason for the compromised virulence. The decreased biofilm formation and virulence upon fukugiside treatment was validated in vivo using C. elegans. The present study is the first of its kind to exhibit the anti-biofilm property of fukugiside against different M serotypes of S. pyogenes and augurs well for its clinical application.
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